Risk factors of angle opening after lens extraction in patients with shallow peripheral anterior chamber.
Yue Fu, Yufeng Chen, Xiuqin Li, Lingzi Huang, Lufan Li, Nan Zhang, Yixin Hu, Wen Zeng, Min Ke
Summary
In patients with shallow peripheral anterior chamber, a smaller preoperative TIA, ICPA and IC predicts unsatisfactory angle opening after LE. Female can also be a risk factor for the narrow angle after LE.
Abstract
PURPOSE
To predict the degree of angle opening after lens extraction (LE) in patients with shallow peripheral anterior chamber.
METHODS
We collected the ultrasound biomicroscopy (UBM) parameters before and one month after LE retrospectively. The binary logistic regression and artificial neural network (ANN) models of angle opening after LE were established using preoperative UBM parameters, and the predictive factors were screened. The performances of models were evaluated using the area under the receiver operator characteristic curve (AUROC).
RESULTS
Patients from the Zhongnan Hospital of Wuhan University were randomized into a training set (n = 91) or a test set (n = 39) for internal validation. External validation employed the entire Zhongnan Hospital cohort as the training set (n = 130) and Dawu County People's Hospital cohort as the test set (n = 30). Both internal and external validation using both models showed that iris curvature (IC), iris-ciliary process angle (ICPA), trabecular-iris angle (TIA), and gender were significantly predictive of the degree of angle opening after LE (p < 0.05). Both models achieved an AUROC of 0.993 (0.997-1.0) in the internal validation training set, and an AUROC of 0.929 (0.774-1.0) in the internal validation test set. In the external validation training set, both models achieved an AUROC of 0.995 (0.984-1.0), while in the external validation test, both models had an AUROC of 0.938 (0.800-1.0).
CONCLUSION
In patients with shallow peripheral anterior chamber, a smaller preoperative TIA, ICPA and IC predicts unsatisfactory angle opening after LE. Female can also be a risk factor for the narrow angle after LE.
Keywords
More by Yue Fu
View full profile →Top Research in Epidemiology & Genetics
Browse all →The Risks and Benefits of Myopia Control.
Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2).
Neuroprotective strategies for retinal disease.
Discussion
Comments and discussion will appear here in a future update.